Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.230
+0.050 (1.57%)
Nov 22, 2024, 4:00 PM EST - Market closed
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $230.19 million as of November 22, 2024. Its market cap has decreased by -73.94% in one year.
Market Cap
230.19M
Enterprise Value
-117.80M
1-Year Change
-73.94%
Ranking
Category
Stock Price
$3.23
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has increased from $129.95M to $230.19M, an increase of 77.13%. That is a compound annual growth rate of 13.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 213.08M | -80.12% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | 2.11B | 1,523.25% |
| Apr 3, 2020 | 129.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eledon Pharmaceuticals | 239.55M |
| Biomea Fusion | 238.45M |
| TruBridge | 237.06M |
| Aurora Cannabis | 236.55M |
| Perspective Therapeutics | 235.54M |
| Quantum-Si incorporated | 234.05M |
| TScan Therapeutics | 228.43M |
| biote | 226.00M |